197 related articles for article (PubMed ID: 29757436)
1. Continuous PTH in Male Mice Causes Bone Loss Because It Induces Serum Amyloid A.
Choudhary S; Santone E; Yee SP; Lorenzo J; Adams DJ; Goetjen A; McCarthy MB; Mazzocca AD; Pilbeam C
Endocrinology; 2018 Jul; 159(7):2759-2776. PubMed ID: 29757436
[TBL] [Abstract][Full Text] [Related]
2. Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts.
Choudhary S; Goetjen A; Estus T; Jacome-Galarza CE; Aguila HL; Lorenzo J; Pilbeam C
J Biol Chem; 2016 Feb; 291(8):3882-94. PubMed ID: 26703472
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.
Choudhary S; Canalis E; Estus T; Adams D; Pilbeam C
PLoS One; 2015; 10(3):e0120164. PubMed ID: 25781979
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin-mediated inhibition of PTH-stimulated β-catenin signaling in osteoblasts by bone marrow macrophages.
Estus TL; Choudhary S; Pilbeam CC
Bone; 2016 Apr; 85():123-30. PubMed ID: 26851123
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C
Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875
[TBL] [Abstract][Full Text] [Related]
6. Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.
Xu M; Choudhary S; Voznesensky O; Gao Q; Adams D; Diaz-Doran V; Wu Q; Goltzman D; Raisz LG; Pilbeam CC
Bone; 2010 Aug; 47(2):341-52. PubMed ID: 20471507
[TBL] [Abstract][Full Text] [Related]
7. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
Liu F; Lee SK; Adams DJ; Gronowicz GA; Kream BE
Bone; 2007 Apr; 40(4):1135-43. PubMed ID: 17275432
[TBL] [Abstract][Full Text] [Related]
8. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
9. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2.
Ferrari SL; Pierroz DD; Glatt V; Goddard DS; Bianchi EN; Lin FT; Manen D; Bouxsein ML
Endocrinology; 2005 Apr; 146(4):1854-62. PubMed ID: 15705780
[TBL] [Abstract][Full Text] [Related]
10. Different duration of parathyroid hormone exposure distinctively regulates primary response genes Nurr1 and RANKL in osteoblasts.
Choi H; Magyar CE; Nervina JM; Tetradis S
PLoS One; 2018; 13(12):e0208514. PubMed ID: 30576321
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone.
Yan J; Sun W; Zhang J; Goltzman D; Miao D
Am J Pathol; 2012 Jul; 181(1):234-44. PubMed ID: 22640808
[TBL] [Abstract][Full Text] [Related]
12. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
13. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.
Maridas DE; Rendina-Ruedy E; Helderman RC; DeMambro VE; Brooks D; Guntur AR; Lanske B; Bouxsein ML; Rosen CJ
FASEB J; 2019 Feb; 33(2):2885-2898. PubMed ID: 30354669
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells.
Shinoda Y; Kawaguchi H; Higashikawa A; Hirata M; Miura T; Saito T; Nakamura K; Chung UI; Ogata N
J Cell Biochem; 2010 Mar; 109(4):755-63. PubMed ID: 20058231
[TBL] [Abstract][Full Text] [Related]
15. Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
Ma YL; Cain RL; Halladay DL; Yang X; Zeng Q; Miles RR; Chandrasekhar S; Martin TJ; Onyia JE
Endocrinology; 2001 Sep; 142(9):4047-54. PubMed ID: 11517184
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.
Ben-awadh AN; Delgado-Calle J; Tu X; Kuhlenschmidt K; Allen MR; Plotkin LI; Bellido T
Endocrinology; 2014 Aug; 155(8):2797-809. PubMed ID: 24877630
[TBL] [Abstract][Full Text] [Related]
17. MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.
Delgado-Calle J; Hancock B; Likine EF; Sato AY; McAndrews K; Sanudo C; Bruzzaniti A; Riancho JA; Tonra JR; Bellido T
FASEB J; 2018 May; 32(5):2878-2890. PubMed ID: 29401593
[TBL] [Abstract][Full Text] [Related]
18. Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism.
Siddiqui JA; Johnson J; Le Henaff C; Bitel CL; Tamasi JA; Partridge NC
Sci Rep; 2017 Nov; 7(1):15300. PubMed ID: 29127344
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I.
Wang Y; Sakata T; Elalieh HZ; Munson SJ; Burghardt A; Majumdar S; Halloran BP; Bikle DD
J Endocrinol; 2006 May; 189(2):279-87. PubMed ID: 16648295
[TBL] [Abstract][Full Text] [Related]
20. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
